AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market
Holding AU:AFP?
Track your performance easily

AFT Pharmaceuticals Ltd. (AFP) Financial Statements

5 Followers

AFT Pharmaceuticals Ltd. Financial Overview

AFT Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.138; its P/E ratio is 17.97; and it has a dividend yield of 0.60%. AFT Pharmaceuticals Ltd. is scheduled to report earnings on November 21, 2024, and the estimated EPS forecast is AU$0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 21Mar 20Mar 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.94M$ 3.21M$ 5.97M$ 6.62M
Total Assets$ 121.76M$ 105.13M$ 84.87M$ 60.90M
Total Debt$ 40.51M$ 42.22M$ 46.02M$ 39.98M
Net Debt$ 32.57M$ 39.01M$ 40.05M$ 33.36M
Total Liabilities$ 65.02M$ 68.54M$ 68.05M$ 56.03M
Stockholders Equity$ 56.74M$ 36.59M$ 16.82M$ 4.88M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History

AFT Pharmaceuticals Ltd. Debt to Assets

AFT Pharmaceuticals Ltd. Cash Flow

AFT Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis